Saw Stephanie P L, Zhong Wen-Zhao, Fu Rui, Li Molly S C, Goto Yasushi, Fox Stephen B, Yatabe Yasushi, Ong Boon-Hean, Ng Calvin S H, Lee David D W, Cam Phuong Pham, Park In Kyu, Yang James C H, Tsuboi Masahiro, Tho Lye Mun, John Thomas, Hsu Hsao-Hsun, Tan Daniel S W, Mok Tony S K, Reungwetwattana Thanyanan, Singh Navneet
Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Boulevard, Singapore 168583, Singapore.
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Lung Cancer. 2025 Feb;200:108076. doi: 10.1016/j.lungcan.2024.108076. Epub 2025 Jan 2.
The peri-operative management of non-small cell lung cancer (NSCLC) in earlier stage disease has seen significant advances in recent years with the incorporation of immune checkpoint inhibitors and targeted therapy. However, many unanswered questions and challenges remain, including the application of clinical trial data to routine clinical practice. Recognising the unique demographic profile of Asian patients with NSCLC and heterogeneous healthcare systems, the Asian Thoracic Oncology Research Group (ATORG) convened a consensus meeting in Singapore on 26 April 2024 to discuss relevant issues spanning diagnostic testing to post-neoadjuvant treatment considerations and future directions. An interdisciplinary group of 19 experts comprising medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists and pathologists from Singapore, Hong Kong, Mainland China, Korea, Japan, Taiwan, India, Malaysia, Thailand, Vietnam and Australia met to discuss emerging data, identify existing gaps in clinical care and develop a multidisciplinary, multinational expert consensus statement on the peri-operative management of NSCLC tailored to the Asia-Pacific region.
近年来，随着免疫检查点抑制剂和靶向治疗的引入，早期非小细胞肺癌（NSCLC）的围手术期管理取得了显著进展。然而，仍有许多未解决的问题和挑战，包括临床试验数据在常规临床实践中的应用。认识到亚洲NSCLC患者独特的人口统计学特征和异质性医疗系统，亚洲胸部肿瘤学研究组（ATORG）于2024年4月26日在新加坡召开了一次共识会议，讨论从诊断测试到新辅助治疗后考虑因素以及未来方向等相关问题。一个由来自新加坡、中国香港、中国大陆、韩国、日本、中国台湾、印度、马来西亚、泰国、越南和澳大利亚的医学肿瘤学家、胸外科医生、放射肿瘤学家、肺科医生和病理学家组成的1跨学科19位专家小组齐聚一堂，讨论新出现的数据，确定临床护理中存在的差距，并就亚太地区NSCLC围手术期管理制定一份多学科、多国专家共识声明。
